SYNTHESIS OF CELENTERAZINE Russian patent published in 2024 - IPC C07D487/04 A61F13/42 B01J20/22 C07B51/00 

Abstract RU 2832144 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a method of producing celenterazine, involving binding 4-(5-amino-6-benzylpyrazin-2-yl)phenol with 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)-1,1-diethoxypropan-2-one to obtain celenterazine. 4-(5-amino-6-benzylpyrazin-2-yl)phenol is obtained (a) by treating 3-benzylpyrazin-2-amine with N-bromosuccinimide to obtain 3-benzyl-5-bromopyrazin-2-amine and (b) by reacting 3-benzyl-5-bromopyrazin-2-amine in two successive steps to obtain 4-(5-amino-6-benzylpyrazin-2-yl)phenol; where (b) provides a first step for reacting 3-benzyl-5-bromopyrazin-2-amine with 4-methoxyphenylboronic acid in the presence of a palladium catalyst - tetrakis(triphenylphosphine)palladium (0) to obtain 3-benzyl-5-(4-methoxyphenyl)pyrazine-2-amine, where the palladium catalyst tetrakis (triphenylphosphine) palladium (0) is present in amount of 5 to 10 percent by weight with respect to 3-benzyl-5-bromopyrazine-2-amine, and the second step is deprotection of 3-benzyl-5-(4-methoxyphenyl)pyrazine-2-amine to obtain 4-(5-amino-6-benzylpyrazin-2-yl)phenol; (c) further provides for coupling 4-(5-amino-6-benzylpyrazin-2-yl)phenol with 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)-1,1-diethoxypropan-2-one from 16 hours to 28 hours, wherein the mixture of solvents contains dioxane, water and HCl; or for 24 hours to 36 hours, wherein the mixture of solvents contains dioxane, methanol and isopropyl alcohol, and mixing the reaction mixture with activated carbon and silicon dioxide. 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)-1,1-diethoxypropan-2-one is synthesized i) by reacting 4-hydroxybenzaldehyde with tert-butyldimethylsilyl chloride to obtain 4-((tert-butyldimethylsilyl)oxy)benzaldehyde; ii) by reacting 4-((tert-butyldimethylsilyl)oxy)benzaldehyde with sodium borohydride to obtain (4-((tert-butyldimethylsilyl)oxy)phenyl)methanol; iii) by reacting (4-((tert-butyldimethylsilyl)oxy)phenyl)methanol with methanesulfonyl chloride to obtain tert-butyl(4-(chloromethyl)phenoxy)dimethylsilane; iv) reacting tert-butyl(4-(chloromethyl)phenoxy)dimethylsilane with magnesium to obtain (4-((tert-butyldimethylsilyl)oxy)benzyl)magnesium chloride and v) by reacting (4-((tert-butyldimethylsilyl)oxy)benzyl)magnesium chloride with ethyl-2,2-diethoxyacetate to obtain 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)-1,1-diethoxypropan-2-one. Invention also relates to embodiments of the method of producing celenterazine.

EFFECT: methods of producing celenterazine with high output and purity.

11 cl, 4 tbl, 5 ex

Similar patents RU2832144C2

Title Year Author Number
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS 2007
  • Mortensen Debora S'Ju
  • Mederos Marija Mersedes Del'Gado
  • Sapienza Dzhon Dzhozef
  • Al'Bers Ronald Dzh.
  • Li Brehnden G.
  • Kharris Roj Leonard Iii
  • Shevlin Graziehlla Izabel
  • Khuan Dekhua
  • Shvarts Kimberli Lin
  • Pakard Garrik K.
  • Parns Dzhejson Sajmon
  • Papa Patrik Uill'Jam
  • Terani Lida Radnija
  • Perren-Ninkovich Sofi
  • Riggz Dzhennifer R.
RU2478635C2
NOVEL CHEMILUMINESCENT SUBSTRATES FOR Xa FACTOR 2019
  • Van Heerde, Waander Laurens
  • Van Geffen, Mark
  • Steeghs, Danique
RU2820234C2
APOPTOSIS-INDUCING AGENTS 2018
  • Liu, Hongbin
  • Rong, Yue
  • Zhang, Huajie
  • Chen, Zhifang
  • Tan, Rui
  • He, Chengxi
  • Li, Zhifu
  • Zhou, Zuwen
  • Tan, Haohan
  • Ran, Kai
  • Wang, Xianlong
  • Zou, Zongyao
  • Jiang, Lihua
  • Liu, Yanxin
  • Zhao, Xingdong
  • Wang, Weibo
  • Fu, Jiemin
RU2782469C2
NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF 2014
  • Van Yun
  • Chzhao Liven
  • Chzhan Syan
  • Bi Shen
  • Gao Ipin
  • Chen Khunyan
  • Van Dechzhun
  • Nan Yan
  • Chzhan Tsan
  • Li Yujsyu
  • Chzhan Di
RU2621709C2
ALPHA-SPIRAL MIMETICS AND METHODS ASSOCIATED WITH THEM 2009
  • Odagami Takenao
  • Kogami Judzi
  • Koudzi Khirojuki
RU2512538C2
LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (KDM1A) INHIBITORS FOR DISEASE THERAPY 2019
  • Tapper, Emi, E..
  • Kelatka, Kassandra
  • Kler, Majkl
  • Renkhoff, Dzhr, Khyu, Yu.
RU2813145C2
SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTICAL METHODS BASED ON THE SAME 2000
  • Aliagas-Martin Ignasio
  • Artis Din R.
  • Dajna Majkl S.
  • Flajgar Dzhon A.
  • Goldsmit Richard A.
  • Manrou Redzhajna A.
  • Olivero Alan G.
  • Pastor Richard
  • Roson Tomas I.
  • Robardzh Kirk D.
  • Suterlin Daniel P.
  • Uiz Kennet Dzh.
  • Dzhou Aje
  • Dzhu Jan'
RU2252935C2
COMPOUNDS TARGETING BRM AND RELATED USES THEREOF 2019
  • Crew, Andrew P.
  • Wang, Jing
  • Berlin, Michael
  • Dragovich, Peter
  • Chen, Huifen
  • Staben, Leanna
RU2797832C2
METHOD AND REAGENTS FOR DETECTING LUCIFERASE ACTIVITY 2020
  • Yampolskij Ilya Viktorovich
RU2826202C2
IMPROVED METHOD FOR SYNTHESIS OF BETA-BLOCKER 2006
  • Gkharpure Milind Moreshvar
  • Bkhaval Baburao Manikrao
  • Sutar Radzhiv Pandurang
  • Mekhta Satish Ramanlal
RU2423346C2

RU 2 832 144 C2

Authors

Duvvuru, Rajagopala Reddy

Bhatt, Rama

Kumar, Anil

Dates

2024-12-19Published

2019-06-28Filed